Henrik Boel-Jørgensen

Stimulation With 0.3-mg Recombinant Human Thyrotropin Prior to Iodine 131 Therapy to Improve the Size Reduction of Benign Nontoxic Nodular Goiter

Viveque Egsgaard Nielsen, Steen Joop Bonnema, Henrik Boel-Jørgensen et al. · Archives of Internal Medicine · 2006 · 95 citations

Medicine, Endocrinology, Nuclear Medicine +17

Improvement of Goiter Volume Reduction after 0.3 mg Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with a Very Large Goiter: A Double-Blinded, Randomized Trial

Steen Joop Bonnema, Viveque Egsgaard Nielsen, Henrik Boel-Jørgensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 89 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +13

Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Large Nodular Goiters Facilitates Tracheal Decompression and Improves Inspiration

Steen Joop Bonnema, Viveque Egsgaard Nielsen, Henrik Boel-Jørgensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 53 citations

Medicine, Nuclear Medicine, Pharmacotherapy +15

Recombinant Human Thyrotropin Markedly Changes the¹³¹I Kinetics during¹³¹I Therapy of Patients with Nodular Goiter: An Evaluation by a Randomized Double-Blinded Trial

Viveque Egsgaard Nielsen, Steen Joop Bonnema, Henrik Boel-Jørgensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 50 citations

Medicine, Endocrinology, Pharmacology +17

Prestimulation with Recombinant Human Thyrotropin (rhTSH) Improves the Long-Term Outcome of Radioiodine Therapy for Multinodular Nontoxic Goiter

Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 41 citations · Full text

Medicine, Endocrinology, Nuclear Medicine +17